Documentos

Debates Datos técnicos Previsión Estacionales

Documentos de BioLineRX Ltd.

Explore los últimos documentos de BioLineRX Ltd., incluyendo documentos regulatorios y divulgaciones corporativas que proporcionan información sobre el rendimiento y la estrategia de la empresa. Utilice estos recursos para respaldar decisiones de inversión informadas.

Socio de datos

Descripción

Reported date

Formato

2025

Q2 2025

Ago 14, 2025

Transcript

Earnings release8-K

Q1 2025

Mayo 27, 2025

Transcript

Earnings release8-K

2024

Q4 2024

Mar 31, 2025

Transcript

Annual report20-F

Earnings release6-K

Q3 2024

Nov 25, 2024

Earnings release8-K

Q2 2024

Ago 15, 2024

Earnings release8-K

Q1 2024

Mayo 28, 2024

Earnings release8-K

2023

Q4 2023

Mar 26, 2024

Annual report20-F

Earnings release8-K

Q3 2023

Nov 20, 2023

Earnings release8-K

FDA Announcement

Sep 12, 2023

Press release

Q2 2023

Ago 30, 2023

Earnings release8-K

Q1 2023

Mayo 24, 2023

Earnings release8-K

2022

Q4 2022

Mar 22, 2023

Annual report20-F

Earnings release8-K

Q3 2022

Nov 15, 2022

Earnings release8-K

Status Update

Sep 28, 2022

Press release

Q2 2022

Ago 16, 2022

Earnings release8-K

Q1 2022

Mayo 11, 2022

Earnings release8-K

2021

Q4 2021

Mar 16, 2022

Annual report20-F

Earnings release8-K

Q3 2021

Nov 18, 2021

Earnings release8-K

Q2 2021

Ago 18, 2021

Earnings release8-K

Q1 2021

Mayo 26, 2021

Earnings release8-K

2020

Q4 2020

Feb 23, 2021

Annual report10-K

2019

Q4 2019

Mar 12, 2020

Annual report10-K

2018

Q4 2018

Mar 28, 2019

Annual report10-K

2017

Q4 2017

Mar 06, 2018

Annual report10-K

2016

Q4 2016

Mar 23, 2017

Annual report10-K

2015

Q4 2015

Mar 10, 2016

Annual report10-K